Literature DB >> 10565906

Molecular epidemiology of vancomycin-resistant Enterococcus faecium in a large urban hospital over a 5-year period.

W E Bischoff1, T M Reynolds, G O Hall, R P Wenzel, M B Edmond.   

Abstract

To investigate the dissemination of vancomycin-resistant Enterococcus faecium (VREF) in a 728-bed tertiary-care hospital, all clinical VREF isolates recovered from June 1992 to June 1997 were typed by pulsed-field gel electrophoresis, and the transfer histories of the patients were documented. A total of 413 VREF isolates from urine (52%), wounds (16%), blood (11%), catheter tips (6%), and other sites (15%) were studied. VREF specimens mostly came from patients on wards (66%) but 34% came from patients in an intensive care unit. The number of VREF isolates progressively increased over time, with higher rates of isolation during the winter months and lower rates in the late summer months. Four distinct banding patterns were detected by pulsed-field gel electrophoresis among 316 samples (76%). Strain A (122 samples; 30%) appeared in June 1992 as the first VREF strain and was found until December 1994 throughout the entire hospital. Type B (92 samples; 22%) was initially detected in January 1994 and disappeared in November 1996. Strain C (10 samples; 2%) was limited to late 1996 and early 1997. Strain D (92 samples; 22%) showed two major peaks during March 1996 to August 1996 and January 1997 to February 1997. Unrelated strains (97 samples; 24%) appeared 1 year after the appearance of the first VREF isolate, and the numbers increased slightly over the years. Nosocomial acquisition (i.e., no known detection prior to admission and first isolation from cultures performed with samples retrieved >/=2 days after hospitalization) was found for 316 (91%) of 347 patients. Despite the implementation of Centers for Disease Control and Prevention guidelines, the proportion of related strains and high number of nosocomial cases of infection indicate a high transmission rate inside the hospital. The results imply an urgent need for stringent enforcement of more effective infection control measures.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10565906      PMCID: PMC85843     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  63 in total

1.  Epidemiological study of hospital-acquired infection with vancomycin-resistant Enterococcus faecium: possible transmission by an electronic ear-probe thermometer.

Authors:  R Porwancher; A Sheth; S Remphrey; E Taylor; C Hinkle; M Zervos
Journal:  Infect Control Hosp Epidemiol       Date:  1997-11       Impact factor: 3.254

2.  Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee.

Authors:  J S Garner
Journal:  Infect Control Hosp Epidemiol       Date:  1996-01       Impact factor: 3.254

3.  Vancomycin control measures at a tertiary-care hospital: impact of interventions on volume and patterns of use.

Authors:  M V Singer; R Haft; T Barlam; M Aronson; A Shafer; K E Sands
Journal:  Infect Control Hosp Epidemiol       Date:  1998-04       Impact factor: 3.254

4.  A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit.

Authors:  S Slaughter; M K Hayden; C Nathan; T C Hu; T Rice; J Van Voorhis; M Matushek; C Franklin; R A Weinstein
Journal:  Ann Intern Med       Date:  1996-09-15       Impact factor: 25.391

5.  Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection.

Authors:  K J Henning; H Delencastre; J Eagan; N Boone; A Brown; M Chung; N Wollner; D Armstrong
Journal:  Pediatr Infect Dis J       Date:  1996-10       Impact factor: 2.129

6.  Presence of vancomycin-resistant enterococci in farm and pet animals.

Authors:  L A Devriese; M Ieven; H Goossens; P Vandamme; B Pot; J Hommez; F Haesebrouck
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

7.  Control of endemic glycopeptide-resistant enterococci.

Authors:  L M Dembry; K Uzokwe; M J Zervos
Journal:  Infect Control Hosp Epidemiol       Date:  1996-05       Impact factor: 3.254

8.  Enterococcus faecium bacteremia: does vancomycin resistance make a difference?

Authors:  V Stosor; L R Peterson; M Postelnick; G A Noskin
Journal:  Arch Intern Med       Date:  1998-03-09

9.  An investigation of vancomycin-resistant Enterococcus faecium within the pediatric service of a large urban medical center.

Authors:  D F McNeeley; A E Brown; G J Noel; M Chung; H De Lencastre
Journal:  Pediatr Infect Dis J       Date:  1998-03       Impact factor: 2.129

10.  Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

Authors:  M B Edmond; J F Ober; D L Weinbaum; M A Pfaller; T Hwang; M D Sanford; R P Wenzel
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

View more
  2 in total

1.  PCR fragment length polymorphism analysis of vancomycin-resistant Enterococcus faecium.

Authors:  S Donabedian; E Hershberger; L A Thal; J W Chow; D B Clewell; B Robinson-Dunn; M J Zervos
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

2.  Enterococcal colonization of infants in a neonatal intensive care unit: associated predictors, risk factors and seasonal patterns.

Authors:  Markus Hufnagel; Cathrin Liese; Claudia Loescher; Mirjam Kunze; Heinrich Proempeler; Reinhard Berner; Marcus Krueger
Journal:  BMC Infect Dis       Date:  2007-09-16       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.